Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy
- PMID: 33298751
- DOI: 10.1097/ADM.0000000000000788
Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy
Conflict of interest statement
The authors report no conflicts of interest.
Comment in
-
Letter in Reply.J Addict Med. 2021 Nov-Dec 01;15(6):526-527. doi: 10.1097/ADM.0000000000000787. J Addict Med. 2021. PMID: 33298752 No abstract available.
Comment on
-
Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review.J Addict Med. 2021 Jan-Feb 01;15(1):74-84. doi: 10.1097/ADM.0000000000000739. J Addict Med. 2021. PMID: 32956162 Free PMC article. Review.
References
-
- Chan B, Gean E, Arkhipova-Jenkins I, et al. Retention strategies for medications for opioid use disorder in adults: A rapid evidence review. J Addict Med 2020; Online Ahead of Print.
-
- Binswanger IA, Stern MF, Deyo RA, et al. Release from prison — A high risk of death for former inmates. N Engl J Med 2007; 356 (2):157–165.
-
- Degenhardt L, Larney S, Kimber J, et al. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Addiction 2014; 109 (8):1306–1317.
-
- Malta M, Varatharajan T, Russell C, Pang M, Bonato S, Fischer B. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review. PLoS Med 2019; 16 (12):e1003002.
-
- Rich JD, McKenzie M, Larney S, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial. Lancet 2015; 386 (9991):350–359.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical